Public Meeting on Drug Supply Chain Security

Federal Register notice: FDA is announcing a 12/7-8 virtual public meeting entitled “Drug Supply Chain Security Act Implementation and Readiness Efforts for 2023.” Topics to be discussed are stakeholder experiences with implementation and overall readiness regarding implementing enhanced drug distribution security requirements that will go into effect on 11/27/2023, standards for the interoperable data exchange of product tracing information, requests for product tracing information or verification from FDA for the purpose of investigating suspect or illegitimate products or for recalls, steps taken to build capacity for package-level tracing, pharmaceutical distribution supply chain best practices, and the impact that the Drug Supply Chain Security Act requirements would have on public health, including patient safety and access to prescription drugs. To view the notice, click here.